184 related articles for article (PubMed ID: 6428718)
1. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
Vernet-der-Garabédian B; Morel E; Bach JF
C R Acad Sci III; 1984; 298(16):449-56. PubMed ID: 6428718
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin.
Vernet-der Garabedian B; Bach JF; Morel E
Clin Exp Immunol; 1987 Apr; 68(1):130-7. PubMed ID: 3652512
[TBL] [Abstract][Full Text] [Related]
3. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
Claudio T; Raftery MA
J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of acetylcholine receptors: different forms of receptor distinguished by alpha-bungarotoxin kinetics and by antibody binding properties.
Massa T; Mittag TW
J Pharmacol Exp Ther; 1983 Nov; 227(2):340-8. PubMed ID: 6631716
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
Vernet-der Garabedian B; Morel E; Bach JF
J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314
[TBL] [Abstract][Full Text] [Related]
7. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
Barkas T; Simpson JA
J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
[TBL] [Abstract][Full Text] [Related]
8. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G
Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
Elias SB; Appel SH
Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
[TBL] [Abstract][Full Text] [Related]
10. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
[TBL] [Abstract][Full Text] [Related]
12. alpha-Bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor.
Vincent A; Newsom-Davis J
Adv Cytopharmacol; 1979; 3():269-78. PubMed ID: 474297
[No Abstract] [Full Text] [Related]
13. Acetylcholine receptors and myasthenia gravis: the effect of antibodies to eel acetylcholine receptors on eel electric organ cells.
Lindstrom J; Einarson B; Francy M
Prog Clin Biol Res; 1977; 15():119-30. PubMed ID: 928444
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
Brenner T; Abramsky O; Lisak RP; Zweiman B; Tarrab-Hazdai R; Fuchs S
Isr J Med Sci; 1978 Sep; 14(9):986-9. PubMed ID: 721428
[No Abstract] [Full Text] [Related]
15. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
[TBL] [Abstract][Full Text] [Related]
16. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.
Drachman DB; Angus CW; Adams RN; Michelson JD; Hoffman GJ
N Engl J Med; 1978 May; 298(20):1116-22. PubMed ID: 643030
[TBL] [Abstract][Full Text] [Related]
17. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
[TBL] [Abstract][Full Text] [Related]
18. [alpha-Bungarotoxin and acetylcholine receptor (author's transl)].
Takamori M; Ishii N; Tsujihata M; Mori M; Kasai M
No To Shinkei; 1977 Jun; 29(6):597-607. PubMed ID: 334200
[No Abstract] [Full Text] [Related]
19. Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis.
Hara H; Hayashi K; Ohta K; Itoh N; Nishitani H; Ohta M
Clin Chem; 1993 Oct; 39(10):2053-7. PubMed ID: 8403390
[TBL] [Abstract][Full Text] [Related]
20. A lipid-associated acetylcholine receptor as an antigen in diagnosis of myasthenia gravis.
Raimond F; Vernet-der-Garabedian B; Morel E
Clin Exp Immunol; 1982 Feb; 47(2):345-50. PubMed ID: 7075027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
